HealthLynked Corp. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
HealthLynked Corp. (HLYK) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$24.29 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-14
- HealthLynked Corp. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was -$13.16K.
- HealthLynked Corp. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was -$53.97K.
- HealthLynked Corp. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was -$223.73K, a 3402.30% decline year-over-year.
- HealthLynked Corp. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was $6.78K.
- HealthLynked Corp. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was $185.33K.
- HealthLynked Corp. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was -$3.23M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$24.29K 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | -$13.16K S-1/A · filed 2026-05-29 | |||
| 2025-12-31 | -$39.10K S-1/A · filed 2026-05-29 | |||
| 2025-09-30 | -$65.33K 10-Q · filed 2025-11-19 | |||
| 2025-06-30 | -$56.04K 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | -$53.97K S-1/A · filed 2026-05-29 | |||
| 2024-12-31 | -$170.98K S-1/A · filed 2026-05-29 | |||
| 2024-09-30 | -$232.26K 10-Q · filed 2025-11-19 | |||
| 2024-06-30 | -$74.52K 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | -$223.73K 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | $185.33K 10-K · filed 2025-03-31 | |||
| 2023-09-30 | -$10.56K 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | $857.08K 10-Q · filed 2024-08-14 | |||
| 2023-03-31 | $6.78K 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | -$3.23M 10-K · filed 2024-04-01 | |||
| 2022-09-30 | -$3.13M 10-Q · filed 2023-11-14 |